MedTrace Logo

The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study

NCT03912961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1034

Last updated 2020-06-05

No results posted yet for this study

Summary

In this clinical trial, we plan to evaluate the usefulness of artificial intelligence (AI) software paired with a handheld retinal camera to compare diabetic retinopathy status in Bolivian patients as read by retina specialists versus the AI software.

Conditions

Interventions

OTHER

Picture of the retina with a handheld retinal camera

Patient with diabetes will have their undilated and dilated images taken, with the images being centered on the macula and on the optic disc.

Sponsors & Collaborators

  • VisionQuest Biomedical LLC

    collaborator INDUSTRY

  • Retina Global

    lead OTHER

Principal Investigators

  • Rajat Agrawal, MD MS · Retina Global

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2019-04-14
Completion
2019-10-15

Countries

  • Bolivia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912961 on ClinicalTrials.gov